Chen J, Sankaranarayanan R, Shen Z
Qidong Liver Cancer Institute, Jiangsu.
Zhonghua Zhong Liu Za Zhi. 1998 May;20(3):202-6.
In the period of 1982-1991, 16,922 patients with cancers from 15 sites of Qidong population-based cancer registry were analysed for evaluation of cancer survival as well as different cancer control measures.
Observed survival rate (OS) was computed by the Kaplan-Meier method using EGRET statistical software package. Relative survival (RS) which is the ratio of the OS to the expected rate was calculated by using Qidong life table with respect to sex, age and calendar period of observation.
The five-year OS for the 5 leading sites of cancers, liver, stomach, lung, oesophagus, and rectum were 1.8%, 11.6%, 3.0%, 3.3%, and 19.9%, respectively. The five-year RS for the 5 sites were 1.9%, 14.0%, 3.6%, 4.2%, and 23.7%, respectively, in which, 1.7%, 14.8%, 3.4%, 4.2%, and 26.0% for males, and 2.7%, 12.7%, 4.1%, 4.0%, and 22.0% for females, respectively. Female patients with breast cancer and cervix cancer had 5-year RS of 54.6% and 33.0%.
Cancer survival rates for all sites are poor, in which that of the liver is the lowest, while that of the breast, the highest. The survivals of cancers for all sites, especially for breast, cervix, and leukaemia are seen to be lower than those of European countries except for oesophagus, pancreas and lung cancer which do not achieve improved survival both in developing and developed countries. There will be a long way to improve the total cancer survival, as well as the cancer treatment in the developing countries.
在1982年至1991年期间，对启东基于人群的癌症登记处15个部位的16922例癌症患者进行分析，以评估癌症生存率及不同的癌症控制措施。
使用EGRET统计软件包通过Kaplan-Meier方法计算观察生存率（OS）。相对生存率（RS）是OS与预期生存率的比值，通过启东寿命表按性别、年龄和观察日历期计算得出。
肝癌、胃癌、肺癌、食管癌和直肠癌这5个主要癌症部位的五年OS分别为1.8%、11.6%、3.0%、3.3%和19.9%。这5个部位的五年RS分别为1.9%、14.0%、3.6%、4.2%和23.7%，其中男性分别为1.7%、14.8%、3.4%、4.2%和26.0%，女性分别为2.7%、12.7%、4.1%、4.0%和22.0%。乳腺癌和宫颈癌女性患者的五年RS分别为54.6%和33.0%。
所有部位的癌症生存率都很低，其中肝癌最低，而乳腺癌最高。除食管癌、胰腺癌和肺癌在发展中国家和发达国家均未实现生存率提高外，所有部位癌症的生存率，尤其是乳腺癌、宫颈癌和白血病的生存率均低于欧洲国家。提高发展中国家的总体癌症生存率以及癌症治疗水平仍有很长的路要走。
Zotero 插件